Topical Anesthetic Abuse Keratopathy

Topical anesthetic abuse keratopathy is a serious injury to the clear front window of the eye (the cornea) that happens when a person uses numbing eye drops again and again without a doctor’s close guidance. These drops are called topical anesthetics. Examples include proparacaine, tetracaine, and oxybuprocaine. In an eye clinic, doctors use these drops briefly to make the eye numb for a test or a small procedure. The drops are not meant to be taken home or used many times, because frequent use is toxic to the living cells on the surface of the cornea.

When someone uses these numbing drops too often, the corneal surface cells become weak, sick, and then die. The thin outer skin of the cornea, called the epithelium, starts to break down. Small open areas form and do not heal well. The cornea can swell, become cloudy, and may develop a ring-shaped sore. The person can feel severe pain at first, then sometimes less pain later because the corneal nerves are damaged. If the damage continues, the middle layer of the cornea (the stroma) can thin and even melt. In the worst cases the cornea can perforate (make a hole), which is an emergency that can threaten sight.

Abuse usually begins after an eye injury, foreign body, contact lens irritation, or after a surgery such as PRK, where a person experiences significant pain. The numbing drop brings quick relief, so the person uses it again and again. Over time, the drop stops helping and starts hurting. The cornea becomes numb and unhealthy. Because infection can also join the picture, the eye can get worse very quickly. This condition is often confused with other causes of a painful red eye, such as herpes simplex keratitis, acanthamoeba keratitis, or fungal keratitis, which is why careful testing is needed.

The key idea: short, one-time medical use of anesthetic drops in a clinic is safe; repeated self-use is dangerous and can cause a sight-threatening corneal disease called topical anesthetic abuse keratopathy.

---

How this damage happens inside the eye

Topical anesthetics block the tiny gates (called sodium channels) in nerve cell membranes. This stops pain signals from traveling to the brain. When this block is used only once or twice, the nerves recover. But frequent use harms many parts of the cornea:

• Surface cell injury: the drops are toxic to epithelial cells. Cell junctions loosen, the protective barrier breaks, and the surface becomes rough and open.

• Nerve damage: corneal nerves are injured and become less sensitive. Nerve loss also stops the normal healing signals that help the epithelium regrow. This creates a neurotrophic (nerve-poor) cornea that heals very slowly.

• Tear film problems: the drops disturb the tears and the natural oil and mucus layers. The cornea dries more easily and shears with blinking.

• Inflammation and enzyme release: the eye releases enzymes (matrix metalloproteinases) that digest damaged tissue. Too much enzyme activity can melt stromal collagen and thin the cornea.

• Secondary infection risk: the broken surface is an open door for bacteria, fungi, or protozoa (like acanthamoeba). Infection makes the damage deeper and more dangerous.

• Toxic ring and pseudo-dendrites: some patients form a ring-shaped infiltrate or line-like surface defects that look like herpes “dendrites” but without the typical rounded ends. This can confuse diagnosis.

---

Who gets it and why it is often missed

This problem can occur in anyone who can access numbing drops outside the clinic, but it is more likely when a person has strong eye pain, easy access to the drops, and little guidance. People with high pain sensitivity, anxiety, or a history of self-medication are at greater risk. It is often missed because the eye looks like other infections and because the patient may not mention using a numbing drop. Clinicians must gently but clearly ask about any “pain-relief” eye drops obtained from friends, pharmacies, or old prescriptions.

---

Types

1. By exposure level

   • Acute misuse: short burst of frequent use over days to a couple of weeks, usually after an injury or procedure. Surface defects appear quickly.

   • Chronic abuse: daily or near-daily use over many weeks or months. The cornea becomes numb, thin, and non-healing, with high risk of melting.

2. By depth and severity

   • Epithelial toxicity only: punctate staining or small non-healing erosions.

   • Epithelial defect with stromal haze: the middle cornea begins to swell and lose clarity.

   • Ring-shaped infiltrate: a circular white ring inside the cornea from intense inflammation, sometimes with sterile (non-infectious) material.

   • Stromal melt / descemetocele: deep thinning down to the last inner membrane.

   • Perforation: a full-thickness hole, often with leakage of fluid; this is an emergency.

3. By confusing appearance (mimics)

   • Pseudo-dendritic keratopathy: looks like herpes but lacks the typical terminal bulbs and does not respond to antivirals alone.

   • Acanthamoeba-like keratitis: severe pain and ring infiltrate can mimic acanthamoeba, especially in contact lens wearers.

   • Fungal-like keratitis: feathery edges or satellite lesions may look fungal.

4. By agent

   • Proparacaine-associated

   • Tetracaine-associated

   • Mixed or compounded high-strength anesthetics

These labels help doctors track how far the condition has progressed and what risks need urgent control.

5. By patterns

1) Early toxic surface disease. The eye is red, light-sensitive, and very painful. The corneal skin has many small defects, and staining shows a rough surface that won’t quickly heal. Pain relief from drops is short-lived, so people re-dose—fueling a toxic cycle. PMC

2) Persistent epithelial defect (non-healing “scratch”). A well-defined area of missing corneal skin lasts for days to weeks. Because nerves are damaged, healing signals are weak—this is similar to neurotrophic keratopathy. PMCAAO

3) Ring keratitis with stromal inflammation. A ring-shaped white infiltrate can form, mimicking Acanthamoeba. Pain is severe, often “too much” for the early exam picture, which should raise suspicion for anesthetic abuse. EyeWikiOftalmoloji

4) Corneal melt and thinning. Enzymes (MMPs) and inflammation dissolve supportive corneal collagen, causing progressive thinning that can rapidly worsen. OftalmolojiScienceDirect

5) Descemetocele or perforation. Only the deepest corneal layer remains (a bulging “bubble”), or a full-thickness hole opens—this is an emergency that may need glue, amniotic membrane, or corneal transplant. Oftalmoloji

6) Chronic stage with scarring and nerve loss. Even after closure, people can be left with haze, irregular surface, long-term dry eye, and decreased corneal sensitivity. Some require regenerative therapy (e.g., cenegermin) or surgery for vision rehabilitation. AAO

---

Causes

These “causes” are factors that start, feed, or worsen the cycle of anesthetic overuse and corneal damage. Many patients have several of these at the same time.

1. Self-medication after a foreign body: after dust or metal gets in the eye, a numbing drop feels wonderful, so the person keeps using it to stop pain. This repeated use injures the cornea.

2. Post-procedure pain (e.g., PRK or corneal scrape): after surface eye surgery, pain can be intense. If someone gets hold of anesthetic drops outside the clinic, they may overuse them.

3. Unregulated pharmacy access: in some places, anesthetic drops can be purchased without proper controls. Easy access increases abuse.

4. Borrowed or leftover drops: a friend or family member shares drops used in a clinic visit. The person thinks “it worked for them; it will work for me,” and keeps using them.

5. Poor understanding of risk: the person believes the drops are like ordinary painkillers. They do not realize the cornea is being poisoned with each repeated dose.

6. High pain sensitivity or anxiety: people who fear pain or who have panic with eye discomfort are at higher risk to repeat dosing.

7. Neuropathic corneal pain: when eye pain is driven by nerves rather than surface injury, anesthetics do not solve the problem. The person keeps dosing to chase pain relief, worsening toxicity.

8. Contact lens discomfort: a contact lens wearer uses anesthetic drops to keep wearing lenses despite irritation. The lens plus the drop creates more damage.

9. Dry eye disease: a dry, unstable tear film makes the cornea fragile. Anesthetic toxicity takes hold quickly on this already stressed surface.

10. Chemical exposure at work: someone with frequent eye irritation at work seeks quick relief with a numbing drop instead of using protective eyewear and proper care.

11. Misdiagnosis as simple “conjunctivitis”: if a painful red eye is mis-treated with casual drops and the person secretly adds anesthetics, the condition can rapidly worsen.

12. Psychiatric comorbidities: depression, substance use disorder, or compulsive behaviors can drive repeated dosing despite harm.

13. Inadequate follow-up after injury: without clear instructions and close check-ups, a person in pain may look for relief with numbing drops found online or at a pharmacy.

14. Compounded high-concentration anesthetics: stronger, compounded drops cause faster and deeper toxicity when misused.

15. Mixing anesthetics with other over-the-counter drops: combining with decongestants or antibiotics does not protect the cornea and may hide early harm.

16. Bottle contamination: a dirty bottle tip seeds bacteria or fungi onto the already damaged cornea, adding infection to toxicity.

17. Iatrogenic over-exposure in clinic: rare, but if multiple doses are used during a long procedure without protection, the surface can be stressed and slower to heal; if the patient then continues dosing at home, damage accelerates.

18. Pain catastrophizing: the belief that pain equals damage makes the person dose more often, even though the dosing is the true source of the damage.

19. Lack of protective tear ointments or bandage lenses after procedures: without safer pain strategies, the person may turn to anesthetic drops.

20. Social sharing or online advice: informal tips from forums or social media can wrongly endorse anesthetic use for eye pain, leading to harmful patterns.

---

Symptoms

1. Severe eye pain at first, then mixed pain later: early on the pain is very strong. As the nerves get damaged, some people feel less surface pain even while the eye gets worse. Others feel deep aching or burning that does not match the exam.

2. Redness: the white of the eye becomes very red due to irritation and inflammation.

3. Tearing and watery discharge: the eye waters a lot as it tries to protect itself.

4. Light sensitivity (photophobia): bright light hurts and makes the eye squeeze shut.

5. Blurred or cloudy vision: the cornea loses its smooth surface and clarity, so vision goes down.

6. Gritty or foreign body sensation: it feels like sand is stuck under the eyelid.

7. Difficulty opening the eye: spasm of the eyelid muscles makes it hard to keep the eye open, especially in bright places.

8. Headache around the eye: pain can spread to the brow, temple, or cheek.

9. Slow healing after a small scratch: small injuries that should heal in a day or two keep reopening or do not close.

10. Worsening pain when the drop wears off: each dose briefly helps, then pain rebounds and feels worse.

11. Halos around lights at night: swelling and surface irregularity create glare and halos.

12. Reduced contact lens tolerance: lenses become very uncomfortable or impossible to wear.

13. Stringy mucus or mild discharge: often due to surface irritation, but any thick or colored discharge may mean infection has joined.

14. Feeling “numb but aching”: the surface can be numb to touch, yet the person reports a deep ache—this is a sign of nerve injury.

15. Sudden sharp pain with moisture leaking: if a hole develops, fluid can leak (a positive Seidel sign), and pain, tearing, and vision drop sharply. This is an emergency.

---

Diagnostic tests

Doctors use a step-by-step plan. They start with basic exams, then add focused tests. The goal is to confirm toxicity, look for infection, measure nerve and tear function, and judge how deep the damage goes.

A) Physical Exam

1. Visual acuity check (letters on a chart): this simple test tells how much vision has dropped. A big drop warns of deeper involvement or swelling. It also creates a baseline to judge improvement.

2. Slit-lamp biomicroscopy with white light: the doctor uses a special microscope with a narrow bright beam to look closely at the cornea. They look for surface roughness, non-healing defects, a ring-shaped infiltrate, swelling, blood vessel growth from the edges, and any signs of melting.

3. Fluorescein staining under cobalt blue light: a safe dye is placed on the eye. Areas where the surface is broken glow green. In anesthetic abuse, there can be large, flat, map-like defects or fine, branching lines that look like herpes but lack the classic rounded ends.

4. Seidel test for leaks: more fluorescein is used to see if aqueous fluid from inside the eye is leaking through a thin spot. A streaming pattern shows a hole, which needs urgent protection.

5. Anterior chamber exam for inflammation: the doctor looks for “cells and flare,” which means inflammation inside the front of the eye. This can happen when the cornea is badly inflamed or infected.

B) Manual Tests

6. Corneal sensitivity test (cotton wisps): a thin cotton thread lightly touches different corneal areas. In this condition, the cornea often feels less than normal because nerves are damaged. Low sensation supports the diagnosis and affects healing plans.

7. Schirmer I test (tear production): a small paper strip is placed under the lower lid for five minutes to measure tear wetting. Poor tearing makes the cornea more fragile and healing slower.

8. Tear breakup time (TBUT): a tiny amount of fluorescein is placed, and the doctor times how quickly dry spots appear between blinks. A short TBUT means the tear film is unstable, which increases friction and damage.

9. Lid eversion and sweeping: the upper lid is flipped to look for trapped debris or a hidden foreign body that might have started the pain cycle. The lid margin and lashes are also checked for blepharitis that can add irritation.

C) Lab and Pathological Tests

10. Corneal scraping for smears (Gram, Giemsa, KOH): a sterile tool gently scrapes the edge and base of the ulcer or defect. The sample is stained and examined to look for bacteria, fungi, or acanthamoeba. This helps separate toxic injury from true infection, or detect both.

11. Microbial cultures (bacteria, fungi, acanthamoeba): samples are placed on culture media to grow organisms. Results guide targeted treatment if infection is present.

12. HSV/VZV PCR (viral detection): if the pattern looks like herpes, a swab can be sent for PCR to detect herpes simplex or zoster DNA. A negative PCR, plus low corneal sensitivity and a history of drop use, supports anesthetic toxicity.

13. Impression cytology of the ocular surface: a tiny membrane touches the surface to collect cells. Under a microscope, the lab can show loss of normal surface cells, goblet cell changes, and inflammation, all consistent with toxic injury.

14. Culture or toxicology of the patient’s drop bottle: if the person brings their bottle, the liquid and the tip can be cultured. Contamination supports mixed toxic-infectious disease. If the bottle is a compounded product, the lab may identify very high concentrations.

D) Electrodiagnostic / Sensory Function Tests

15. Non-contact (gas) corneal esthesiometry: a gentle puff of air or gas at different strengths measures how sensitive the cornea is without touching it. People with anesthetic abuse usually need stronger stimuli to feel touch, showing reduced nerve function.

16. Blink reflex testing (trigeminal pathway): rarely needed, but in difficult cases a neuro-ophthalmic lab can test the blink reflex to check if the pain pathway is abnormal. Abnormalities support neuropathic pain contributions.

E) Imaging Tests

17. In vivo confocal microscopy (IVCM): this is a special microscope that takes “micro-photos” of living cornea layers. It can show loss or beading of subbasal nerves, inflammatory cells, and whether there are cysts or structures that suggest acanthamoeba or fungus. In toxicity, nerves are reduced and irregular.

18. Anterior segment optical coherence tomography (AS-OCT): this scan shows cross-sections of the cornea. It measures how thick or thin the cornea is, shows areas of melt, and helps decide if a protective procedure like gluing or a patch is needed.

19. Corneal pachymetry (thickness mapping): this test, by ultrasound or OCT, measures corneal thickness across the surface. Thinning points are tracked over time to see if melting is getting worse or stabilizing.

20. Corneal topography/tomography (surface map): this map shows how smooth or irregular the cornea has become. It helps explain blurry vision and guides later rehabilitation once healing begins.

Non-pharmacological treatments

(Each item includes Description → Purpose → Mechanism.)

1. Immediate cessation of topical anesthetic.
   Stop the numbing drops completely. → Purpose: remove the toxin. → Mechanism: halts ongoing epithelial toxicity, nerve injury, and enzyme-driven corneal melt. This is the single most important step. PMC

2. Patient education and addiction-aware counseling.
   Explain that repeat dosing causes worsening pain and damage. → Purpose: prevent relapse. → Mechanism: insight reduces compulsive re-use; referral to mental-health/addiction care when appropriate. AAO Journal

3. Protective eye shield and activity modification.
   Wear a rigid shield; avoid rubbing and wind/dust. → Purpose: reduce further trauma. → Mechanism: limits mechanical micro-injury to fragile epithelium.

4. Frequent preservative-free lubricants.
   Use non-medicated, preservative-free artificial tears often. → Purpose: comfort and surface protection. → Mechanism: dilutes inflammatory mediators and reduces friction; avoid preservatives that worsen toxicity. PMC

5. Therapeutic bandage contact lens (carefully).
   A soft lens can cover the defect. → Purpose: pain relief and epithelial migration “scaffold”. → Mechanism: reduces eyelid shear; requires close monitoring and prophylactic antibiotic because of infection risk. PMC

6. Temporary tarsorrhaphy.
   Gently sew eyelids partly closed. → Purpose: moisture chamber to speed healing. → Mechanism: reduces exposure and evaporation; often combined with drops/serum/AMT. PMC

7. Therapeutic amniotic membrane transplantation (AMT).
   Sutured or self-retained (e.g., cryopreserved ring device). → Purpose: promote re-epithelialization, reduce pain/inflammation. → Mechanism: biologic bandage with growth factors and anti-inflammatory properties; helpful in neurotrophic and non-healing ulcers. PMCLippincott JournalsScienceDirect

8. Pressure patching (select cases).
   Short-term patch over lubricated eye. → Purpose: decrease friction in small, sterile defects. → Mechanism: immobilizes lid–cornea interface; avoid if infection is suspected.

9. Scleral lens (PROSE) after healing phase.
   Custom large lens vaults over cornea in chronic stage. → Purpose: visual rehab and surface protection. → Mechanism: fluid reservoir bathes epithelium; not for acute melts.

10. Pain management without topical anesthetics.
    Use cold compresses, dark glasses, guided relaxation. → Purpose: reduce pain while avoiding toxic drops. → Mechanism: non-pharmacologic analgesia supports adherence to cessation. (Medication options listed later.)

11. Debridement of loose epithelium.
    Gently remove non-adherent edges. → Purpose: let healthy cells migrate. → Mechanism: fresh, well-adherent rim improves closure.

12. Punctal occlusion (plugs) for dry surface.
    Block tear drainage. → Purpose: increase natural lubrication time. → Mechanism: retains tears and medications on the eye.

13. Humidification and blink hygiene.
    Room humidifier, blink breaks, screens at eye-level. → Purpose: decrease evaporation. → Mechanism: stabilizes tear film.

14. Nutritional support and hydration.
    Adequate fluids, protein, and vitamin C–rich foods. → Purpose: collagen synthesis and healing. → Mechanism: supports stromal repair co-factors. (Evidence for ascorbate’s role in corneal wound repair is biologically plausible; see also oral vitamin C use with melts below.) Dspace

15. In-clinic de-escalation plan and drop accountability.
    Doctor controls all drops and checks frequently. → Purpose: prevent relapse. → Mechanism: supervised care, no refills of anesthetics.

16. Allergy/atopy control if present.
    Manage lid disease or allergy. → Purpose: reduce surface inflammation that impedes healing. → Mechanism: lowers cytokines/MMPs that degrade epithelium. PubMed

17. Photophobia aids.
    Tinted lenses and hats. → Purpose: comfort and adherence. → Mechanism: reduces light-triggered pain.

18. Psychological support.
    Address anxiety, insomnia, or dependence. → Purpose: sustain cessation. → Mechanism: CBT, brief therapy, or addiction consults help behavior change. AAO Journal

19. Close follow-up (often every 24–72 hours initially).
    Re-check healing, IOP, and infection signs. → Purpose: catch deterioration early. → Mechanism: timely intervention prevents perforation.

20. Care transitions plan.
    Hand-off to corneal specialist and, if needed, pain/addiction specialists. → Purpose: comprehensive recovery. → Mechanism: team-based care for surface, vision, and relapse prevention. PMC

---

Drug treatments

Important: medication plans must be individualized by an eye specialist. Doses below are typical starting points from common practice or literature; they are not personal medical advice.

1. Broad-spectrum topical antibiotic (e.g., moxifloxacin 0.5% q.i.d. or equivalent).
   Class: fluoroquinolone. → Time: during open defect. → Purpose: infection prophylaxis with bandage lens or epithelial defect. → Mechanism: inhibits bacterial DNA gyrase/topoisomerase. → Side effects: burning, rare allergy; avoid unnecessary prolonged use to limit resistance.

2. Cycloplegic (e.g., homatropine 5% b.i.d.).
   Class: antimuscarinic. → Time: acute pain phase. → Purpose: ciliary spasm relief, photophobia reduction. → Mechanism: relaxes ciliary body and sphincter. → Side effects: dry mouth, blurry near vision.

3. Oral analgesic (acetaminophen ± cautious short opioid if truly necessary).
   Class: analgesic/opioid. → Time: severe acute pain. → Purpose: systemic pain relief without topical anesthetics. → Mechanism: central analgesia. → Side effects: sedation, constipation with opioids; strict short-term plan only. (Emergency-medicine literature discusses short-term topical anesthetic for simple abrasions under strict control, but not for TAAK; in TAAK, further anesthetic use is harmful.) Annals of Emergency MedicineAAO

4. Topical NSAID (careful, often avoided if epithelial defect is large).
   Class: NSAID (e.g., ketorolac). → Time: limited cases for pain in tiny defects; many cornea specialists avoid during active melts. → Purpose: pain reduction. → Mechanism: COX inhibition lowers prostaglandins. → Side effects: delayed healing, rare corneal melt—use only with specialist oversight. (Evidence supports NSAIDs for simple abrasions, but caution is warranted in toxic keratopathy.) Wiley Online Library

5. Oral doxycycline (50–100 mg b.i.d.).
   Class: tetracycline antibiotic with anti-collagenase activity. → Time: during stromal thinning or high MMP activity. → Purpose: slow corneal melt. → Mechanism: chelates metal ions and down-regulates MMP-9, reducing collagen breakdown. → Side effects: GI upset, photosensitivity; avoid in pregnancy/children. PMCPubMedIOVS

6. Oral vitamin C (ascorbic acid 500–1000 mg/day).
   Class: nutrient. → Time: with thinning/melt. → Purpose: support collagen cross-linking and healing. → Mechanism: cofactor for collagen synthesis; may reduce stromal degradation. → Side effects: GI upset at high doses. (Supportive evidence and biological rationale from corneal melt literature.) Dspace

7. Topical N-acetylcysteine (e.g., 5–10% compounded q.i.d.).
   Class: mucolytic/anti-collagenase. → Time: active melt or filamentary mucus. → Purpose: reduce MMP-driven breakdown and filaments. → Mechanism: inhibits MMP-9 production and inflammatory signaling. → Side effects: stinging; requires compounding. PMCScienceDirectLippincott Journals

8. Topical corticosteroid (low-to-moderate potency, short course after epithelium begins to close; specialist only).
   Class: anti-inflammatory. → Time: when infection excluded and epithelium is improving; may be avoided in early open ulcers. → Purpose: dampen sterile inflammation that perpetuates melt. → Mechanism: reduces cytokines and MMP expression. → Side effects: delayed epithelialization, increased IOP, infection risk—expert use only. PubMed

9. Autologous serum tears (20–50% up to q1–2h, then taper).
   Class: biologic tear substitute. → Time: persistent defects or neurotrophic state. → Purpose: supply growth factors and vitamins similar to natural tears to speed epithelial healing. → Mechanism: epitheliotrophic factors (EGF, fibronectin) promote cell migration/adhesion. → Side effects: requires blood draw/sterile compounding; refrigeration. PubMedPMC

10. Cenegermin (Oxervate) 0.002% (20 µg/mL) q6/day × 8 weeks.
    Class: recombinant human nerve growth factor. → Time: confirmed neurotrophic keratopathy from nerve damage (Stages 1–3), often after the toxic phase is controlled. → Purpose: regenerate corneal nerves and restore healing reflexes. → Mechanism: NGF binds TrkA receptors → supports nerve survival/regrowth; RCTs show higher complete healing rates vs vehicle. → Side effects: eye pain, redness; costly. FDA Access DataNCBIPMC

---

Dietary molecular supplements

(Discuss these with your clinician; they are adjuncts, not cures.)

1. Vitamin C (500–1000 mg/day). Supports collagen cross-linking → cofactor for prolyl/lysyl hydroxylases in stromal repair. Dspace

2. Omega-3 fatty acids (e.g., 1–2 g/day EPA/DHA). Anti-inflammatory milieu → shifts eicosanoids toward pro-resolving mediators; may stabilize tear film.

3. Vitamin A (within recommended dietary range only). Epithelial differentiation → retinoid signaling supports mucin production; avoid excess.

4. Vitamin D (per lab-guided repletion). Immune modulation → regulates innate immunity and wound healing pathways.

5. Zinc (10–20 mg elemental/day for limited period). Collagen synthesis cofactor → supports matrix remodeling.

6. L-lysine (1 g/day, if herpetic history present; clinician-guided). May reduce HSV reactivation risk → competes with arginine in viral replication pathways (adjunct only).

7. Curcumin (standardized extract per label). Anti-inflammatory/antioxidant → down-modulates NF-κB signaling (adjunct; interactions possible).

8. N-acetylcysteine oral (600 mg 1–2×/day). Systemic precursor of glutathione → antioxidant and potential MMP modulation; complements topical NAC. Lippincott Journals

9. Collagen peptides (per label). Provide amino acid building blocks → may support general collagen turnover.

10. Hydration + adequate dietary protein (≈1.0–1.2 g/kg/day if appropriate). Tissue repair → supplies substrates for corneal extracellular matrix.

---

Regenerative / stem-cell”-type therapies

1. Cenegermin (NGF) eye drops (approved). See above—most robust regenerative evidence for corneal nerves in neurotrophic keratopathy; improves epithelial stability and sensitivity in many patients. FDA Access DataNCBI

2. Autologous serum tears / Platelet-rich plasma (PRP) tears. Blood-derived growth factors support healing in neurotrophic and persistent defects; PRP offers higher platelet-borne cytokines in some protocols. PubMed

3. Amniotic membrane (sutured or self-retained). A biologic graft rich in growth factors that reduces inflammation and fosters epithelialization; widely used with supportive evidence. Lippincott JournalsScienceDirect

4. Scleral prosthetic devices (PROSE) after healing. Not a “drug,” but a regenerative-support tool—continuous fluid reservoir can restore surface health and visual function long-term.

5. Limbal stem cell transplantation (e.g., SLET/CLET) for chronic limbal stem cell deficiency. In select severe, chronic cases with stem-cell loss from toxicity, transplanting limbal epithelium can restore a healthy surface; specialized centers only.

6. Biologic anti-MMP strategies (adjuncts). Oral doxycycline and topical NAC (from the drug list) act as anti-collagenase measures to stabilize melts, creating a permissive environment for regeneration to proceed. PMC+1

---

Surgeries

1. Amniotic membrane transplantation (AMT).
   Procedure: place biological membrane over the cornea, sutured or in a ring device. → Why: rapid pain relief, anti-inflammatory effect, and faster epithelial closure in persistent defects/neurotrophic state. PMCLippincott Journals

2. Temporary or permanent tarsorrhaphy.
   Procedure: partially sew eyelids together. → Why: protects and humidifies the surface to allow healing when exposure or neurotrophic issues prevent closure.

3. Cyanoacrylate glue with bandage lens.
   Procedure: apply sterile tissue adhesive to a tiny perforation or deep, focal thinning, then cover with a lens. → Why: emergency “patch” to seal leaks and stabilize until definitive surgery. PMC

4. Lamellar or penetrating keratoplasty (corneal transplant).
   Procedure: replace diseased corneal layers (lamellar) or full thickness (PK). → Why: structural repair and optical rehabilitation after scarring/perforation once inflammation is quiet. PubMed

5. Conjunctival flap (Gundersen) in non-healing, high-risk eyes.
   Procedure: swing vascularized conjunctiva over cornea. → Why: bring blood supply and anti-collagenase factors to a hostile surface when other options fail.

---

Preventions

1. Never self-use or refill topical anesthetics. These are procedure-room medicines, not home painkillers. AAO

2. Educate at first visit. Explain the harm and the “rebound pain trap.” AAO

3. Preservative-free strategy for surface disease. Reduce cumulative toxicity. PMC

4. Use safer pain plans (oral meds, cycloplegics). Avoid anesthetic “quick fixes.” Annals of Emergency Medicine

5. Close follow-up of any non-healing abrasion. Early referral to cornea specialist.

6. Limit pharmacy access to topical anesthetics. No refills; clinic-only use. AAO

7. Screen for risk factors (dry eye, exposure, contact lens over-wear). Treat the terrain.

8. Address mental-health/addiction risks. Offer support early. AAO Journal

9. Document “no anesthetic” in the chart for at-risk patients. Shared safety.

10. Provide written instructions and a 24–72-hour check. Reinforce the plan.

---

When to see a doctor

• Immediately if you used a numbing drop outside a clinic and now have severe eye pain, light sensitivity, tearing, or blurred vision—especially if pain keeps returning when the drop wears off.

• Immediately if you notice a white ring on the cornea, a sudden drop in vision, new discharge, or the eye looks gray/irregular—these can signal melt or perforation.

• Urgently (same day) for any non-healing “scratch” that still hurts after 24–48 hours, or any bandage contact lens with increasing pain/redness. These situations can turn dangerous quickly. Oftalmoloji

---

What to eat and what to avoid

What to eat:

• Hydrating fluids and balanced protein daily to support tissue repair.

• Vitamin-C–rich foods (citrus, berries, peppers) for collagen support.

• Omega-3 sources (fish, flax, walnuts) to promote a calmer tear film.

• Colorful vegetables and leafy greens for antioxidants.

What to avoid:

• Smoking or vaping, which impairs ocular healing.

• Excess alcohol or sedatives that can worsen dryness and adherence.

• Very spicy, dehydrating, or ultra-processed foods before bed that may worsen dryness (minor effect, but every bit helps).

• Unproven eye “drops” or home mixes—stick with clinician-provided, preservative-free products.

(Diet helps the body heal, but cannot replace medical/surgical care in TAAK.) Dspace

---

Frequently asked questions

1) Why do numbing drops feel so good—but do so much harm?
They switch off pain nerves briefly, so you feel better. But they also poison healing cells and corneal nerves, so damage worsens in the background. When the drop wears off, pain rebounds—leading to a vicious cycle of re-use and injury. PMC

2) How is TAAK different from a normal corneal abrasion?
A simple abrasion usually heals in 24–72 hours with lubrication and protection. In TAAK, healing stalls because of toxicity and nerve damage; defects persist and melts can develop. PMC

3) Why do doctors worry about Acanthamoeba with this picture?
Both can show ring-shaped inflammation and severe pain. Acanthamoeba needs anti-amoebic therapy; TAAK needs anesthetic cessation and surface regeneration. High suspicion and targeted tests help distinguish them. EyeWiki

4) Will my vision recover?
Many patients improve if the anesthetic is stopped early and the surface is protected. Deep scarring, melts, or perforations may require transplants, and some have lasting sensitivity loss. Outcomes are much better with early treatment. PMC

5) Are bandage contact lenses safe?
They can speed healing and cut pain, but they raise infection risk; that’s why they’re paired with prophylactic antibiotics and close follow-up. PMC

6) Do steroids help or hurt?
They can calm sterile inflammation but may delay epithelial closure and raise infection risk. In TAAK they’re specialist-only, usually after the surface starts closing and infection is excluded. PubMed

7) What are “anti-collagenase” treatments?
They slow the enzymes (like MMP-9) that chew corneal collagen during melts. Examples are oral doxycycline and topical N-acetylcysteine; vitamin C supports collagen repair. PMC+1

8) What if the cornea develops a hole?
Small holes may be sealed with medical glue and a protective lens. Larger or unstable defects often need a corneal transplant after the eye quiets down. PMCPubMed

9) Are autologous serum tears the same as regular tears?
They’re made from your own blood and contain growth factors similar to natural tears. They can speed closure in non-healing defects and neurotrophic keratitis. PubMed

10) What is cenegermin—and when is it used?
It’s a lab-made nerve growth factor eye drop approved for neurotrophic keratopathy. It helps corneal nerves recover and improves healing in many patients after the toxic phase is controlled. FDA Access DataNCBI

11) Can I ever use numbing drops again?
Not at home. In a clinic, your doctor may use them once for procedures. At home they’re unsafe and can rapidly restart damage.

12) How long does healing take after stopping the anesthetic?
In case series of anesthetic-abuse keratopathy, epithelial healing took a median ~17 days (range about 6–50) with appropriate care—timelines vary by severity. PMC

13) Why do preservatives matter?
Some preservatives add toxicity. During healing we prefer preservative-free lubricants and medicines whenever possible. PMC

14) What’s the follow-up schedule?
Often every 24–72 hours early on, then weekly as stability returns—more often if a bandage lens, glue, or AMT is in place. PMC

15) How can clinics prevent anesthetic abuse?
Keep anesthetics as in-office only, educate patients, avoid refills, and coordinate with pharmacies and mental-health services when risk is identified. AAO

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 28, 2025.